NASDAQ · MOBXW

Mobix Labs, Inc.

$0.08 -$0.00 (-0.73%) 1D Market open

Key Metrics

$801.87K
Market cap
0.13×
P/E · TTM
−$2.84M
Revenue · TTM
$6.15M
Net income
EPS · TTM $0.63
Dividend yield
Free cash flow
Beta · 1Y 1.49
EBITDA · TTM
Gross margin 68.5%

The Story So Far

LAST 6 MONTHS PRIMARY SOURCES ONLY
  • Jul 23
    From its Mar 6 high, the share price fell 75%.

    Peak close $0.30 on Mar 6; trough close $0.08 on Jul 23. The drawdown is the fact — the chapters around it are the context.

    RECEIPT: PRICE SERIES, PEAK-TO-TROUGH -75%
  • Jul 16
    Money rotated out of high-beta cohorts market-wide.

    High-beta names lagged the blue-chips by 20.3 points over ten sessions around this date. Stocks in that cohort weren't falling alone — they fell together.

    RECEIPT: ROTATION GAUGE, LIVE
  • Mar 6
    The stock moved +80.3% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 6
  • Mar 3
    The stock moved +281.4% in a single session.

    Sessions this size usually pair with a chapter above or below — a filing, a headline, or the whole cohort moving together.

    RECEIPT: DAILY BAR, Mar 3

The story updates itself as events post · The wolf reports; you decide

Snapshot

Market cap
Enterprise value
Shares outstanding
52-wk range$0.03 – $0.32
Avg volume · 20D27.8K
Net cash
Book value / share$0.90
IndustrySemiconductors & Related Devices
ExchangeNASDAQ
About Mobix Labs, Inc.
IPO dateDec 22, 2023
Employees46

Mobix Labs Inc designs, develops and sells components and systems for wireless and wired connectivity, radio frequency (RF), switching and electromagnetic interference (EMI) filtering technologies.

Wolf Grade COMING SOON

The wolf is in training. Composite grades vs sector — profitability, health, value, momentum — arrive with the percentile engine. Methodology will be public.

Valuation

P/E0.13
P/S
P/FCF
EV/EBITDA
EV/Sales
Graham №$3.56

Profitability

Gross 68.5%
Operating -216.5%
Net -217.0%
FCF
ROE / ROIC 85.6% · —

Financial Health

Current ratio0.23
Quick ratio0.17
Debt / equity0.73
Debt / EBITDA
Net cash
Working capital−$18.54M

Cash Flow · TTM

Operating CF
Capex
Free cash flow
Buybacks
Dividends paid
Shareholder yield

Piotroski F-Score

0 / 9
Weak fundamentals · 0 of 9 signals passing

Altman Z-Score

-6.8
Distress zone (< 1.81) · elevated risk

Graham Number vs Price

$3.56 vs $0.08
Trades below classic defensive value — Graham-cheap
Fundamentals through 2026-03-31 · computed by TickerWolf from SEC filings